Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × pembrolizumab × Thoracic × Clear all

Status

Sponsor Class

INDUSTRY 302 OTHER 195 NIH 12 NETWORK 5 OTHER_GOV 2 FED 2 INDIV 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Genitourinary 1 Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Adenocarcinoma 1

Interventions

sargramostim 1 pembrolizumab 1 pegfilgrastim 1 Mifepristone 1 Ipilimumab 1 Corlux 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03695835 2020-07-22

NIRPA

Gary Onik MD

GastrointestinalGenitourinaryThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡